Back to results
US 9,867,821 B2Granted
Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds
AssigneesSumitomo Dainippon Pharma Co., Ltd., Merck Sharp & Dohme Corp.
InventorsMark T. Bilodeau, Kausik K. Nanda, B. Wesley Trotter
Life of this patent
Estimating the term…
Abstract
The present invention is directed to therapeutic agents which are atypical antipsychotics and which are useful in the treatment of neurological and psychiatric disorders associated with dopamine D2 and serotonin 5-HT2A neurotransmission dysfunction.
Claims15
A compound which is:
- or a pharmaceutically acceptable salt thereof.
A compound which is:
A compound which is:
- in the form of a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.